TABLE 3.
Follow‐up | n | Marginal mean b (g/dL) | Change from baseline (%) | Change from previous c (%) | Cumulative change (%) |
---|---|---|---|---|---|
Baseline | 468 | 4.03 (4.01‐4.05) | — | — | — |
15 days | 468 | 4.00 (3.98‐4.02) | −0.9 | −0.9 | −0.9 |
1 month | 468 | 3.98 (3.96‐4.00) | −1.3 | −0.4 | −1.3 |
3 months | 468 | 3.93 (3.91‐3.95) | −2.7 | −1.4 | −2.7 |
6 months | 468 | 3.95 (3.93‐3.97) | −2.0 | 0.7 | −2.0 |
9 months | 468 | 3.96 (3.94‐3.98) | −1.9 | 0.0 | −2.0 |
12 months | 468 | 3.99 (3.97‐4.01) | −1.2 | 0.8 | −1.2 |
Abbreviation: PP, per‐protocol defined as patients who received all treatments with the MCO membrane during the follow‐up period or until hospitalization that involved >12 dialysis sessions without MCO or death.
Only patients in the PP population who had baseline and all six scheduled serum albumin measurements during HDx were included in the analysis.
Marginal mean is the means estimation based on the fitted model in repeated measures and are presented as 95% confidence interval.
The percentual change from the last measurement value.